Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 25Squamous Cell Carcinoma of Head and Neck 10Lung Neoplasms 10Neoplasms 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Esophageal Squamous Cell Carcinoma 5Breast Neoplasms 5Pancreatic Neoplasms 4Carcinoma, Squamous Cell 4Stomach Neoplasms 3Esophageal Neoplasms 3Brain Neoplasms 3Prostatic Neoplasms 2Non-small-cell Lung Cancer With Somatic EGFR Mutations 2NSCLC 2Glioblastoma 2Colorectal Neoplasms 2Adenocarcinoma of Lung 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Unilateral HER2 Positive Breast Cancer 1Triple Negative Breast Neoplasms 1Thrombocytosis 1Thoracic Neoplasms 1Squamous Cell Cancers of the Head and Neck 1Solid Tumors 1Small Cell Lung Carcinoma 1Skin Neoplasms 1

Interventions

Trastuzumab 4tucatinib 3Capecitabine 3fludarabine 2Spinal Puncture 2Nivolumab 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2pertuzumab 1patritumab deruxtecan 1omburtamab I-131 1gadopiclenol 1gadobutrol 1fludarabine phosphate 1avelumab 1aldesleukin 1WP 744 1Temozolomide 1Specimen Handling 1Rituximab 1Radiotherapy 1Phlebotomy 1Methotrexate 1Mesna 1Interleukin-2 1Blood Specimen Collection 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Meningeal Neoplasms × Afatinib × Clear all
NCT03711422 2022-06-14

Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC

National Cancer Centre, Singapore

Phase 1 Terminated
2 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡